Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chung, Byung Ha ^a   Lim, Sun Woo ^a   Doh, Kyoung Chan ^a   Piao, Shang Guo ^a   Heo, Seong Beom ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYCLOSPORIN;

8 HYDROXYDEOXYGUANOSINE BLOOD LEVEL; 8 HYDROXYDEOXYGUANOSINE URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CELL TRACKING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; DETERIORATION; DISEASE EXACERBATION; HUMAN; HUMAN ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY FUNCTION TEST; MALE; MESENCHYMAL STEM CELL; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; URINE LEVEL;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CELL LINE; CULTURE MEDIA, CONDITIONED; CYCLOSPORINE; DEOXYGUANOSINE; FIBROSIS; HUMANS; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 84875430413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059693     Document Type: Article

References (43)

1. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM, (1996) Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 50: 1089-1100.
2. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M, (1984) Cyclosporine-associated chronic nephropathy. N Engl J Med 311: 699-705.
3. Wang C, Salahudeen AK, (1995) Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int. 47: 927-934.
4. Yang CW, Faulkner GR, Wahba IM, Christianson TA, Bagby GC, et al. (2002) Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am J Transplant 2: 391-399.
5. Yoon HE, Yang CW, (2009) Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 24: 81-92.
6. Picinich SC, Mishra PJ, Glod J, Banerjee D, (2007) The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 7: 965-973.
7. Nauta AJ, Fibbe WE, (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
8. Hematti P, (2008) Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22: 262-273.
9. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI, (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419-427.
10. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, et al. (2010) Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation 121: 2211-2220.
11. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, et al. (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-1635.
12. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG, (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18: 2486-2496.
13. Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R, et al. (2006) Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 24: 1185-1193.
14. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, et al. (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20: 1297-1308.
15. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, et al. (2006) Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 17: 2443-2456.
16. Ghee JY, Han DH, Song HK, Kim WY, Kim SH, et al. (2008) The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy. Nephrol Dial Transplant 23: 4061-4069.
17. Hoogduijn MJ, Crop MJ, Korevaar SS, Peeters AM, Eijken M, et al. (2008) Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Transplantation 86: 1283-1291.
18. Zhang W, Qin C, Zhou ZM, (2007) Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant Proc 39: 3404-3408.
19. Horn AP, Bernardi A, Luiz Frozza R, Grudzinski PB, Hoppe JB, et al. (2011) Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus. Stem cells and development 20: 1171-1181.
20. Horn AP, Frozza RL, Grudzinski PB, Gerhardt D, Hoppe JB, et al. (2009) Conditioned medium from mesenchymal stem cells induces cell death in organotypic cultures of rat hippocampus and aggravates lesion in a model of oxygen and glucose deprivation. Neuroscience research 63: 35-41.
21. da Silva Meirelles L, Caplan AI, Nardi NB, (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299.
22. Rojas M, Xu J, Woods CR, Mora AL, Spears W, et al. (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152.
23. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745.
24. Ahn KO, Li C, Lim SW, Song HK, Ghee JY, et al. (2008) Infiltration of nestin-expressing cells in interstitial fibrosis in chronic cyclosporine nephropathy. Transplantation 86: 571-577.
25. Redondo-Horcajo M, Lamas S, (2005) Oxidative and nitrosative stress in kidney disease: a case for cyclosporine A. J Nephrol. 18: 453-457.
26. Yoon HE, Ghee JY, Piao S, Song JH, Han DH, et al. (2011) Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 26: 800-813.
27. Han DH, Piao SG, Song JH, Ghee JY, Hwang HS, et al. (2010) Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation 90: 135-141.
28. Deters M, Strubelt O, Younes M, (1997) Reevaluation of cyclosporine induced hepatotoxicity in the isolated perfused rat liver. Toxicology 123: 197-206.
29. Owunwanne A, Shihab-Eldeen A, Sadek S, Junaid T, Yacoub T, et al. (1993) Is cyclosporine toxic to the heart? J Heart Lung Transplant 12: 199-204.
30. Djouad F, Fritz V, Apparailly F, Louis Plence P, Bony C, et al. (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis 52: 1595-1603.
31. Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Alwayn IP, et al. (2009) Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 87: 896-906.
32. Muller MH, Poncet C, Prosperi JM, Santoni S, Ronfort J, (2006) Domestication history in the Medicago sativa species complex: inferences from nuclear sequence polymorphism. Mol Ecol 15: 1589-1602.
33. Zhou HP, Yi DH, Yu SQ, Sun GC, Cui Q, et al. (2006) Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 38: 3046-3051.
34. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, et al. (2006) Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81: 1589-1595.
35. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, et al. (2009) Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27: 3063-3073.
36. Togel F, Hu Z, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-42.
37. Kim JH, Park DJ, Yun JC, Jung MH, Yeo HD, et al. (2012) Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302: F1141-1150.
38. Magnasco A, Corselli M, Bertelli R, Ibatici A, Peresi M, et al. (2008) Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplant 17: 1157-1167.
39. Mohammadzadeh M, Halabian R, Gharehbaghian A, Amirizadeh N, Jahanian-Najafabadi A, et al. (2012) Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress Chaperones 17: 553-565.
40. Sun CK, Chang CL, Lin YC, Kao YH, Chang LT, et al. (2012) Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats. Crit Care Med 40: 1279-1290.
41. Whone AL, Kemp K, Sun M, Wilkins A, Scolding NJ, (2012) Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor. Brain Res 1431: 86-96.
42. Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, et al. (2011) Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 9: 51.
43. Choi HJ, Kim JM, Kwon E, Che JH, Lee JI, et al. (2011) Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoral segmental defect model. J Korean Med Sci 26: 482-491.